PGAA Index for Evaluating Patient with Alcoholic Liver Disease

Purpose: To evaluate a patient with alcoholic liver disease using the PGAA index of Naveau et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with alcoholic liver disease?

Yes

Prothrombin activity as percent of normal (enter a whole number from 0 to 100)

Serum GGT

Serum apolipoprotein A1

mg/dL

Serum alpha-2-macroglobulin

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Total PGAA score

Percentage of people with this score who have no or minimal liver disease

Percentage of people with this score who have cirrhosis

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Clinical Diagnosis, Including Family History For Genetics
Imaging Studies
- Intrahepatic Cholestasis Associated with Alcoholic Liver Disease
Laboratory Tests
Other Testing
Criteria For Diagnosis
- Discriminant Function of Maddrey et al and the Modified Discriminant Function of Carithers et al for Steroid Therapy in Severe Alcoholic Hepatitis
- Criteria for Severe Alcoholic Hepatitis
Severity, Prognosis, Stage
Complications
- Discriminant Function of Maddrey et al and the Modified Discriminant Function of Carithers et al for Steroid Therapy in Severe Alcoholic Hepatitis
Differential Diagnosis And Mimics, Red Flags
- Recognition of Acetaminophen Hepatotoxicity in Chronic Alcoholics
- ANI Model for Evaluating Patient with Steatohepatitis

Therapy

Selection

Monitoring

Disease Progression
- Alcoholic Liver Disease | Combined Clinical & Laboratory Index (CCLI)

Specialty

Gastroenterology
Toxicology

Objective

laboratory tests
other testing

ICD-10

K70.3 - Alcoholic cirrhosis of liver
K70.9 - Alcoholic liver disease, unspecified

Info

Purpose: To evaluate a patient with alcoholic liver disease using the PGAA index of Naveau et al.

Specialty: Gastroenterology, Toxicology

Objective: laboratory tests, other testing

ICD-10: K70.3, K70.9,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path